• New CNS partnership between Boehringer and Autifony pharmatimes
    December 19, 2017
    Germany’s Boehringer Ingelheim and Cambridge, UK-based Autifony Therapeutics have announced a new collaboration focused on a novel therapeutic approach to a range of CNS disorders.
PharmaSources Customer Service